Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques.

Further translational research, including clinical experiments, teratogenicity tests, and in-vitro or in-vivo studies, will be performed to evaluate the expression of these identified biomarkers regarding the prognosis of skin cancer patients.